2d
Queerty on MSNA once-a-year PrEP injection? The results of the first clinical trial look promisingPharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The ...
That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...
Prescription drugs like lorazepam — used to treat anxiety, panic attacks and sleep disorders — play a role in popular TV ...
Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide. “We feel that a product like an oral, orforglipron, could serve a significant ...
As a daily pill-taker, I’ve learned that the phrase “Out of sight, out of mind” holds all too true when it comes to staying on top of my medications. A pill case that looks and feels nice ...
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
The federal agency’s new alert is about counterfeit drugs claiming to have semaglutide — the key ingredient in weight loss ...
After getting a search warrant, officers seized over seven pounds of methamphetamine, 12 bags of an unidentified drug, two large bags of suspected heroin, and approximately 5,000 fentanyl pills ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
Findings from MINT will be presented at the American Academy of Neurology Annual Meeting on April 8, 2025, in San Diego.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results